Methyl 13-cis-4-Oxoretinoate

CAS No. 71748-57-7

Methyl 13-cis-4-Oxoretinoate( Methyl 13-cis-4-Oxoretinoate )

Catalog No. M19030 CAS No. 71748-57-7

4-Keto 13-cis-Retinoic Acid is a retinoic acid metabolite in neuroblastoma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 157 In Stock
2MG 88 In Stock
5MG 161 In Stock
10MG 237 In Stock
25MG 427 In Stock
50MG 613 In Stock
100MG 873 In Stock
200MG Get Quote In Stock
500MG 1748 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl 13-cis-4-Oxoretinoate
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Keto 13-cis-Retinoic Acid is a retinoic acid metabolite in neuroblastoma.
  • Description
    Methyl 13-cis-4-Oxoretinoate is a bioactive chemical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Methyl 13-cis-4-Oxoretinoate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    71748-57-7
  • Formula Weight
    314.42
  • Molecular Formula
    C20H26O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(C(CCC1=O)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)OC)/C)/C
  • Chemical Name
    Methyl (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2',5'-Dideoxyadenosi...

    2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site (IC50: 3 μM).2',5'-Dideoxyadenosine (20-150 mM), like adenosine, dependently and reversibly inhibits the positive inotropic and chronotropic effect of beta-adrenergic stimulation with isoproterenol (8-54 pmol) up to 70% and 50%, respectively.

  • Peptide F, bovine

    Peptide F, bovine

  • CT-2584

    CT-2584 is an anticancer agent that inhibits phospholipid signaling and kills tumor cells through the production of reactive oxygen intermediates.